Avestar Capital’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.41M Buy
5,809
+820
+16% +$304K 0.13% 122
2026
Q1
$1.35M Buy
4,989
+56
+1% +$16.7K 0.09% 176
2025
Q4
$1.63M Sell
4,933
-558
-10% -$189K 0.11% 149
2025
Q3
$1.9M Buy
5,491
+1,285
+31% +$389K 0.12% 137
2025
Q2
$1.31M Sell
4,206
-2,992
-42% -$1.14M 0.09% 165
2025
Q1
$3.77M Sell
7,198
-106
-1% -$54.2K 0.33% 63
2024
Q4
$3.69M Buy
7,304
+518
+8% +$294K 0.31% 67
2024
Q3
$3.97M Sell
6,786
-132
-2% -$74.7K 0.41% 54
2024
Q2
$3.52M Sell
6,918
-55
-0.8% -$27K 0.36% 57
2024
Q1
$3.45M Buy
6,973
+975
+16% +$496K 0.36% 57
2023
Q4
$3.16M Buy
5,998
+766
+15% +$409K 0.36% 53
2023
Q3
$2.64M Buy
5,232
+140
+3% +$68.9K 0.38% 55
2023
Q2
$2.45M Sell
5,092
-59
-1% -$28.9K 0.39% 43
2023
Q1
$2.43M Sell
5,151
-235
-4% -$113K 0.43% 43
2022
Q4
$2.86M Sell
5,386
-401
-7% -$212K 0.52% 42
2022
Q3
$2.92M Buy
5,787
+133
+2% +$69.9K 0.74% 35
2022
Q2
$2.9M Sell
5,654
-3,352
-37% -$1.68M 0.71% 34
2022
Q1
$4.59M Sell
9,006
-237
-3% -$114K 0.73% 29
2021
Q4
$4.64M Buy
9,243
+1,685
+22% +$763K 0.57% 39
2021
Q3
$2.95M Buy
7,558
+423
+6% +$175K 0.38% 59
2021
Q2
$2.86M Buy
7,135
+1,440
+25% +$574K 0.38% 69
2021
Q1
$2.25M Buy
5,695
+1,653
+41% +$573K 0.5% 34
2020
Q4
$1.42M Buy
4,042
+1,298
+47% +$435K 0.39% 46
2020
Q3
$886K Buy
2,744
+132
+5% +$40.5K 0.29% 75
2020
Q2
$770K Sell
2,612
-350
-12% -$100K 0.34% 75
2020
Q1
$739K Buy
2,962
+109
+4% +$30K 0.4% 68
2019
Q4
$838K Sell
2,853
-143
-5% -$37.4K 0.47% 53
2019
Q3
$651K Buy
2,996
+747
+33% +$180K 0.4% 56
2019
Q2
$526K Sell
2,249
-63
-3% -$15.2K 0.33% 57
2019
Q1
$549K Sell
2,312
-55
-2% -$14K 0.36% 51
2018
Q4
$558K Sell
2,367
-133
-5% -$35.1K 0.38% 49
2018
Q3
$641K Buy
2,500
+20
+0.8% +$5.2K 0.37% 42
2018
Q2
$582K Buy
2,480
+355
+17% +$85.2K 0.37% 47
2018
Q1
$431K Buy
2,125
+255
+14% +$58.2K 0.28% 54
2017
Q4
$393K Buy
+1,870
New +$396K 0.29% 48

Other funds holding UNH

Avestar Capital's UNH Position: Q2 2026 in Review

Avestar Capital increased its UnitedHealth (UNH) stake by 16% in Q2 2026, buying an estimated $304K and bringing the position to 5,809 shares worth $2.41M. The position accounts for 0.13% of the portfolio, ranked #122.

Avestar Capital first reported a position in UNH in Q4 2017 and has held it in 35 quarters since. The position peaked at $4.64M in Q4 2021. 1,515 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Avestar Capital held 5,809 shares of UnitedHealth worth $2.41M as of Q2 2026.
  • Avestar Capital bought 820 UnitedHealth shares in Q2 2026, an estimated $304K.
  • UnitedHealth made up 0.13% of Avestar Capital's portfolio in Q2 2026, its #122 holding.
  • Avestar Capital first reported a position in UnitedHealth in Q4 2017 and has held it in 35 quarters since.
  • Avestar Capital's UnitedHealth position peaked at $4.64M in Q4 2021.
  • 1,515 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.